Concepedia

Lingli Wang

LW

Statistics

Publications

116

Citations

7.1K

H-Index

45

Active since

2002

Affiliations

Stanford University(Current)

Cardiovascular Institute of the South

Stanford Medicine

Army Medical University

Guangzhou University of Chinese Medicine

Lingli Wang is an author at Stanford University specializing in life sciences, molecular biology, and pulmonary hypertension.

ORCID

Publications per year

2002–2024

116

Publications

116

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension

Edda Spiekerkoetter, Xuefei Tian, Jie Cai et al. · Journal of Clinical Investigation · 2013 · 444 citations · Full text

, , +16

An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension

Georg Hansmann, Vinicio A. de Jesús Pérez, Tero‐Pekka Alastalo et al. · Journal of Clinical Investigation · 2008 · 369 citations · Full text

, , +17

Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation

Georg Hansmann, Roger A. Wagner, Stefan Schellong et al. · Circulation · 2007 · 365 citations

, , +14

A Transcriptional Profile of Aging in the Human Kidney

Graham E. J. Rodwell, Rebecca Sonu, Jacob M. Zahn et al. · PLoS Biology · 2004 · 342 citations · Full text

, , +17

Disruption of PPARγ/β-catenin–mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival

Tero‐Pekka Alastalo, Molong Li, Vinicio de Jesús Pérez et al. · Journal of Clinical Investigation · 2011 · 255 citations · Full text

, , +13

1–5 of 116